Similar Articles
The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke
Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu
DOI: 10.4274/tnd.2019.09735
Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study
Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler
DOI: 10.4274/tnd.2019.33341
Inflammation with Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Restless Legs Syndrome
Ali Zeynalabidin Tak, Yıldızhan Şengül
DOI: 10.4274/tnd.2019.84758
The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal
DOI: 10.4274/tnd.2019.04207
Quality of Life in Patients with Drug Resistant Epilepsy
Hari Krishan Aggarwal, Deepak Jain, Avina Bishnoi
DOI: 10.4274/tnd.2019.31391
What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance
Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk
DOI: 10.4274/tnd.2019.93206
Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
Bahar Say, Ufuk Ergün
DOI: 10.4274/tnd.2019.87513
Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes
İpek Güngör Doğan
DOI: 10.4274/tnd.2019.97720
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
DOI: 10.4274/tnd.2019.75725
The Relationship Between 25 (OH) Vitamin D Level and the Severity of Disease and Sleep Quality in Restless Legs Syndrome
Arife Çimen Atalar
DOI: 10.4274/tnd.2019.25478
Inflammation with Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Restless Legs Syndrome
Sora Yasri, Viroj Wiwanitkit
DOI: 10.4274/tnd.2019.26443
Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
Halil Önder
DOI: 10.4274/tnd.2019.05925
Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort
Ayşe İlksen Çolpak, Duygu Gülmez Sevim, Aslı Tuncer, Sevda Diker, Rana Karabudak, Sibel Kadayıfçılar, Tülay Kansu
DOI: 10.4274/tnd.2018.33230
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Miraç Ayşen Ünsal
DOI: 10.4274/tnd.2019.00187
Comparisons of Akathisia and Restless Legs Syndrome: An Electrophysiologic Study
Bengi Gül Türk, Ayşegül Gündüz, Sinem Metin, Barış Metin, Derya Karadeniz, Meral E. Kızıltan
DOI: 10.4274/tnd.92679
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years
Nefati Kıylıoğlu
DOI: 10.4274/tnd.79836
Posterior Auricular Muscle Response: Observations in Brainstem Lesions
Yeşim Gülen Abanoz, Yasin Abanoz, Yasemin Akıncı, Ayşegül Gündüz, Eser Buluş, Melih Tütüncü, Sabahattin Saip, Meral Erdemir Kızıltan
DOI: 10.4274/tnd.57255
Evaluation of Inflammation with Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Restless Legs Syndrome
Ali Zeynal Abidin Tak, Yıldızhan Şengül
DOI: 10.4274/tnd.98474
Effect of Deep Brain Stimulation on Quality of Life in Patients with Parkinson’s Disease
Esra Doğru Hüzmeli, Atilla Yılmaz
DOI: 10.4274/tnd.49260
Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.86977